TCF-1 and LEF-1 help launch the T(FH) program.
Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan and the RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Kanagawa, Japan.
Masato
M
Kubo
D002454:Cell Differentiation / Q000235:genetics*; D018858:Germinal Center / Q000378:metabolism; D006801:Humans; D017578:Immunoglobulin Class Switching; D051821:Lymphoid Enhancer-Binding Factor 1 / Q000235:genetics*; D008562:Membrane Glycoproteins / Q000378:metabolism; D054400:Receptors, CCR7 / Q000378:metabolism; D054380:Receptors, CXCR5 / Q000378:metabolism; D051822:T Cell Transcription Factor 1 / Q000235:genetics*; D013601:T-Lymphocytes / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000378:metabolism*
D051821:Lymphoid Enhancer-Binding Factor 1; D008562:Membrane Glycoproteins; C084882:P-selectin ligand protein; D054400:Receptors, CCR7; D054380:Receptors, CXCR5; D051822:T Cell Transcription Factor 1